Current Duke Appointments & Affiliations
Assistant Professor of Medicine
·
2022 - Present
Medicine, Medical Oncology,
Medicine
Member of the Duke Cancer Institute
·
2022 - Present
Duke Cancer Institute,
Institutes and Centers
Recent Scholarly Works
Clinical and genomic predictors of sipuleucel-T outcomes in men with metastatic androgen pathway modulator resistant prostate cancer.
Journal article Res Sq · July 1, 2026 BACKGROUND Survival outcomes following sipuleucel-T in men with metastatic androgen pathway modulator resistant prostate cancer (mAPMR) are variable. Genomic alterations influencing immune response and tumor proliferation may explain outcome heterogeneity. ... Full text Link to item CiteAssociation between smoking, tumor genetics, and outcomes in men with metastatic prostate cancer.
Conference Journal of Clinical Oncology · June 1, 2026 5052Background: Smoking has been associated with increased metastatic prostate cancer ... Full text CiteEMETPRO: a multicentric, international, retrospective analysis evaluating patients with metastatic hormone-sensitive prostate cancer with early progression.
Journal article Prostate Cancer Prostatic Dis · May 29, 2026 BACKGROUND: Androgen deprivation therapy (ADT) + androgen receptor pathway inhibitor (ARPI) ± docetaxel represent the standard of care in patients with metastatic hormone-sensitive prostate cancer (mHSPC). However, some patients still have early progressi ... Full text Link to item CiteRecent Grants
Intermittent Fasting using a Fasting-Mimetic Diet to Improve Prostate Cancer Control and Metabolic Outcomes
ResearchCo Investigator · Awarded by Cedars Sinai Medical Center · 2023 - 2028View All Grants
Education
Georgetown University, School of Medicine ·
2016
M.D.